Case Study: Fortune 500 Bio-Pharmaceutical Firm achieves on-time, low-error SAP go-live and active data governance with Syniti

Fortune 500 Bio-Pharmaceutical Firm - Customer Case Study

The Fortune 500 Bio-Pharmaceutical Firm faced a high‑stakes SAP migration to replace an aging JD Edwards system across multiple countries and languages, with an aggressive European go‑live driven by patent expirations. Limited internal SAP experience, missing and inconsistent master data, strict confidentiality rules, and tight timelines threatened on‑time delivery. The company engaged Syniti for data migration and passive/active data governance to keep the conversion business‑focused and on schedule.

Syniti conducted a thorough data audit and used an iterative "load early, load often" conversion approach with cross‑conversion tables and an 80% threshold to prioritize essential records, while handling confidential data and minimizing customizations. Syniti’s solution produced an almost error‑free, on‑time "boring" go‑live (Europe November 2006; North America April 2008), delivered monitoring and Active/Passive Data Governance in production, and established measurable data‑quality reporting and conversion targets to sustain ongoing improvements.